EBOS Group (ASX:EBO, NZE:EBO) reported Wednesday fiscal half-year diluted earnings of AU$0.569 per share, down from AU$0.71 per share a year earlier.
Analysts polled by FactSet expected EPS of AU$0.71.
Revenue for the six months ended Dec. 31, 2024, was AU$5.99 billion, down 9% from AU$6.58 billion a year earlier. Analysts surveyed by FactSet expected AU$5.73 billion in sales revenue.
The healthcare products distributor maintained its guidance of underlying earnings before interest, taxes, depreciation, and amortization of between AU$575 million and AU$600 million for the fiscal year, up 5% to 10% year on year.
The board declared a dividend of NZ$0.57 per share, unchanged from the previously reported period, payable on March 21 to shareholders of record as of Feb. 28.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。